Skip to main content



Purpose & Achievements

Improving Health & Medicine

Research at the Weizmann Institute of Science has led to improved health and better medicine for people everywhere.

Weizmann scientists discovered the basis of amniocentesis and new fertility treatments; discovered Copaxone® and Rebif®, today two of the frontline treatments for multiple sclerosis (MS); and developed a technology used in advanced medical imaging scans.

They are creating diabetes vaccines and flu vaccines; using stem cells to grow new organs and T cells to treat damaged spines; and studying the origins of life and the origins of disease. Institute scientists are also advancing into the future of medicine: at its new Nancy and Stephen Grand Israel National Center for Personalized Medicine, treatments and therapies designed for the individual patient will become a reality.

From understanding the origins of disease to developing the basis for new medicines, the Institute’s basic science research is leading to a healthier world.

Weizmann by the Numbers

Weizmann research led to two
of the first-line drugs for treating multiple sclerosis (MS):
Copaxone® and Rebif®

Chances of pregnancy double after our biopsy-based fertility treatment

Prof. Ada Yonath: first woman in 45 years – just the fourth in history – to win the Nobel in Chemistry, and the first Israeli female laureate

    Highlights

    20.09.2023
    Cancer alters cellular waste-processing machinery, helping it avoid detection by the immune system
    31.08.2023
    A protein facilitating nerve cell repair in the peripheral nervous system might one day point to treatments for neurodegenerative diseases
    08.08.2023
    Weizmann Institute researchers identify a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free treatment
    01.08.2023
    A new study in mice could pave the way to personalized therapy for depression, anxiety and other stress-related disorders known to produce different effects on men and women
    08.05.2023
    Wasting syndrome – a deadly cancer side-effect – might be diagnosed and treated early on, according to a new study
    03.05.2023
    Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission
    01.05.2023
    Weizmann scientists revealed the step-by-step production of cannabinoids in a South African plant, pointing to new ways of manufacturing them for medical use
    27.04.2023
    Identifying the cells producing the hormone EPO may lead to the development of new therapies for treating anemia resulting from kidney disease and other conditions
    11.07.2023
    Innovator, leader, philanthropist
    24.01.2023
    Prof. Nir Yosef is combining single-cell genomic sequencing with a powerful partner: artificial intelligence
    24.01.2023
    Dr. Tslil Ast is looking for therapeutic targets in devastating diseases
    24.01.2023
    A physicist by training, Dr. Eyal Karzbrun is now exploring the physical forces that guide organ formation